[go: up one dir, main page]

CR9545A - Metodos para sintetizar derivados de 6-alquilaminoquinolina - Google Patents

Metodos para sintetizar derivados de 6-alquilaminoquinolina

Info

Publication number
CR9545A
CR9545A CR9545A CR9545A CR9545A CR 9545 A CR9545 A CR 9545A CR 9545 A CR9545 A CR 9545A CR 9545 A CR9545 A CR 9545A CR 9545 A CR9545 A CR 9545A
Authority
CR
Costa Rica
Prior art keywords
methods
alquilaminoquinolina
synthesizing derivatives
directed
formula
Prior art date
Application number
CR9545A
Other languages
English (en)
Inventor
Warren Chew
Sridhar Krishna Rabindran
Caroyln Discafani-Marro
John Patrick Ii Mcginnis
Allan Wissner
Youchu Wang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9545A publication Critical patent/CR9545A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion esta dirigida a un metodo para sintetizar compuestos de Formula (I), en donde X, Z, V, R1, R3, R4, G2, n, x, y, yz son como se define aqui. Esta invencion tambien incluye un metodo para preparar compuestos de acido de Formula (VII), en donde R es H, y R4, x, y, yz son como se define aqui y PG es un grupo protector. Esta invencion esta tambien dirigida a (E) N-{4-[3-cloro-4-(2-piridinilmetoxi)anilino]-3-ciano-7-etoxi-6-quinolinil}-4-(metilamino)-2-butenamida, composiciones que contienen estos metodos para utilizar en el tratamiento del cancer.
CR9545A 2005-05-25 2007-11-23 Metodos para sintetizar derivados de 6-alquilaminoquinolina CR9545A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68504005P 2005-05-25 2005-05-25

Publications (1)

Publication Number Publication Date
CR9545A true CR9545A (es) 2008-01-10

Family

ID=36794434

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9545A CR9545A (es) 2005-05-25 2007-11-23 Metodos para sintetizar derivados de 6-alquilaminoquinolina

Country Status (20)

Country Link
US (1) US20060270670A1 (es)
EP (1) EP1883630A2 (es)
JP (1) JP2008542266A (es)
KR (1) KR20080016604A (es)
CN (1) CN101180273A (es)
AR (1) AR054192A1 (es)
AU (1) AU2006249596A1 (es)
BR (1) BRPI0610142A2 (es)
CA (1) CA2608589A1 (es)
CR (1) CR9545A (es)
GT (1) GT200600215A (es)
IL (1) IL187301A0 (es)
MX (1) MX2007014774A (es)
NO (1) NO20075726L (es)
PA (1) PA8676301A1 (es)
PE (1) PE20070007A1 (es)
RU (1) RU2007140957A (es)
TW (1) TW200716556A (es)
WO (1) WO2006127203A2 (es)
ZA (1) ZA200710143B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008942A2 (en) * 2005-07-11 2007-01-18 Aerie Pharmaceuticals, Inc. Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
ES2580108T3 (es) * 2005-07-11 2016-08-19 Aerie Pharmaceuticals, Inc Compuestos de isoquinolina
JP5235887B2 (ja) 2006-09-20 2013-07-10 アエリー ファーマシューティカルズ インコーポレイテッド Ｒｈｏキナーゼ阻害剤
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8455514B2 (en) * 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
WO2009151910A2 (en) * 2008-05-25 2009-12-17 Wyeth Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
ES2672624T3 (es) 2009-05-01 2018-06-15 Aerie Pharmaceuticals, Inc. Inhibidores de mecanismo doble para el tratamiento de enfermedades
KR20120016053A (ko) 2009-05-14 2012-02-22 코오롱생명과학 주식회사 알킬아민 유도체의 제조방법
ES2624845T3 (es) 2010-09-29 2017-07-17 Intervet International B.V. Compuestos de N-heteroarilo con unidad de puente cíclico para el tratamiento de enfermedades parasitarias
AR083200A1 (es) 2010-09-29 2013-02-06 Intervet Int Bv Compuestos de n-heteroarilo
CN102649778A (zh) * 2011-02-23 2012-08-29 苏州波锐生物医药科技有限公司 喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途
WO2013152135A1 (en) * 2012-04-04 2013-10-10 Dawei Zhang Substituted quinolines as bruton's tyrosine kinases inhibitors
PT3811943T (pt) 2013-03-15 2023-03-15 Aerie Pharmaceuticals Inc Composto para uso no tratamento de distúrbios oculares
WO2014177038A1 (en) 2013-04-28 2014-11-06 Sunshine Lake Pharma Co., Ltd. Aminoquinazoline derivatives and their salts and methods of use thereof
CN108601355B (zh) 2015-11-17 2021-03-30 爱瑞制药公司 制备激酶抑制剂及其中间体的方法
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
CN108290867B (zh) * 2016-04-28 2022-02-08 江苏恒瑞医药股份有限公司 一种制备酪氨酸激酶抑制剂及其衍生物的方法
MX2019002396A (es) 2016-08-31 2019-07-08 Aerie Pharmaceuticals Inc Composiciones oftalmicas.
BR112019020078A2 (pt) 2017-03-31 2020-04-28 Aerie Pharmaceuticals Inc compostos e composições farmacêuticas à base de arilciclopropil-amino-isoquinolinil amida e métodos de uso dos mesmos
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
KR102713340B1 (ko) * 2022-11-08 2024-10-02 경희대학교 산학협력단 고리화첨가 반응과 고리축소 반응의 연속 반응을 이용한 피롤로[1,2-a]퀴놀린의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
US6288082B1 (en) * 1998-09-29 2001-09-11 American Cyanamid Company Substituted 3-cyanoquinolines
US6297258B1 (en) * 1998-09-29 2001-10-02 American Cyanamid Company Substituted 3-cyanoquinolines
BR0109165A (pt) * 2000-03-13 2003-04-22 American Cyanamid Co Método de tratamento de pólipos colÈnicos
UA77200C2 (en) * 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
BR0307375A (pt) * 2002-02-05 2004-12-07 Wyeth Corp Processo para a sìntese de ácidos n-acil-2-amino-4-alcóxi-5-nitro-benzóicos
CL2004000016A1 (es) * 2003-01-21 2005-04-15 Wyeth Corp Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.
BRPI0413667A (pt) * 2003-08-19 2006-10-24 Wyeth Corp Processo para a preparação de 4-amino-3-carbonitrilas de quinolina
SG149817A1 (en) * 2004-01-16 2009-02-27 Wyeth Corp Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof

Also Published As

Publication number Publication date
RU2007140957A (ru) 2009-06-27
PE20070007A1 (es) 2007-02-12
EP1883630A2 (en) 2008-02-06
WO2006127203A3 (en) 2007-05-03
AU2006249596A1 (en) 2006-11-30
CN101180273A (zh) 2008-05-14
NO20075726L (no) 2008-02-04
CA2608589A1 (en) 2006-11-30
ZA200710143B (en) 2008-11-26
KR20080016604A (ko) 2008-02-21
US20060270670A1 (en) 2006-11-30
BRPI0610142A2 (pt) 2011-01-04
TW200716556A (en) 2007-05-01
WO2006127203A2 (en) 2006-11-30
GT200600215A (es) 2006-12-26
JP2008542266A (ja) 2008-11-27
PA8676301A1 (es) 2009-03-31
AR054192A1 (es) 2007-06-06
IL187301A0 (en) 2008-04-13
MX2007014774A (es) 2008-02-19

Similar Documents

Publication Publication Date Title
CR9545A (es) Metodos para sintetizar derivados de 6-alquilaminoquinolina
AR061924A1 (es) Proceso para elaborar 2- amino -5 - halobenzamidas 3- sustituidas
ATE533775T1 (de) Verfahren zur herstellung von 17-vinyl-triflaten als intermediate
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
AR103508A2 (es) PROCESO PARA LA PREPARACIÓN DE OXI-(1H)-QUINOLIN-2-ONAS 5-(a-HALOACETILO)-8-SUSTITUIDAS
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
DE602004009943D1 (de) 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung
PL362766A1 (en) Novel imidazole derivatives, production method thereof and use thereof
PT1606288E (pt) Derivados de benzenossulfonamida, processo para a sua preparação e a sua utilização para tratamento da dor
CR9472A (es) Derivados de aminoacidos
BR0311810A (pt) Preparação revestida, processo para a produção e uso da mesma, processo para a produção de pelo menos uma ração e/ou aditivo para rações contendo pelo menos um diformiato, e, ração para animais
UY30673A1 (es) Derivados 6, 7 y 8 sustituidos del acido (3r)-5-oxo-2,3-dihidro-5h-tiazolo[3,2a]piridin-3-carboxilico, composiciones farmacéuticas conteniéndolos y aplicaciones.
DE602005018238D1 (de) Halbsynthetisches verfahren zur herstellung von 10-desacetyl-n-desbenzoyl-paclitaxel
ES2164293T3 (es) Procedimiento para la fabricacion de pigmentos amarillos de oxido de hierro y su uso.
AR057451A1 (es) Metodos para preparar derivados de acido glutamico
AR055882A1 (es) Un producto mejorado para preparar cabergolina
PE20060951A1 (es) Proceso sintetico para la preparacion de compuestos aromaticos biciclicos
CY1109434T1 (el) Νεα διαδικασια και ενδιαμεσα παρασκευης ενωσεων 19-nor-στερο-des-17-αλογονων
BR0113944A (pt) Processo para a produção de compostos quirais
ES2167777T3 (es) Procedimiento para la preparacion de paclitaxel.
AR053597A1 (es) Procedimiento para fabricar derivados 4-azaesteroide fluorados
DE69931974D1 (de) N-Cyclopropyl-2-difluormethoxy-3-bromanilin und ein Zwischenprodukt zu seiner Herstellung
DE60137352D1 (de) Nsalze, verfahren zur herstellung von beiden und ihre verwendung
AR036680A1 (es) Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)